Asia-Pacific Economic Cooperation, APEC,APAC ( Asia Pacific)
03-04-2026
Work Detail
Chemical Screening And Optimization Facility (X01 Clinical Trial Not Allowed The Nichd Has A State-Of-The-Art Chemical Synthesis And Optimization Facility For Advancing Both Non-Hormonal Contraceptive And Reproductive Health Related Product Development. This Facility Has The Capabilities And Capacity For Preclinical Services Including Investigational Device Exemption (Ide) Or Investigational New Drug (Ind)-Enabling Studies (E.G., Protein Generation, X-Ray Crystallography, High Throughput Screening, Structure Activity Relationships, Hit-To-Lead Generation, Drug Metabolism). The Long-Term Objective Is To Enable A Preclinical Candidate For Ind/Ide Study(Ies) That Offers A Safe Therapeutic Option In The Field Of Contraception, And/Or Reproductive Health Related Indications (Pending Contractor Availability And Available Funding
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
